companydata.dkcompanydata.dk

GlyProVac ApS: Financial statements 2022

CVR: 39724758

Source: annual report 2022, Danish Business Authority

01/07/2021 – 30/06/2022

GlyProVac ApS (CVR 39724758) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,321,135 and a net result of DKK -633,455 compared with DKK -487,049 the year before. That is an increase of 33% compared with the year before. Equity in the 2022 report amounted to DKK 4,976,516. The solvency ratio was 40.7%. The company had 4 employees in the financial year.

Gross Profit
DKK 1,321,135
Profit/Loss
DKK -633,455
Equity
DKK 4,976,516
Total Assets
DKK 12,232,304
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-1.3 mio.-633 t.5 mio.4
2021-993 t.-487 t.2.4 mio.3
2020-1.1 mio.-699 t.672 t.4
2019-145 t.-918 t.1.4 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GlyProVac ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Allan Rosetzsky joins the board of GlyProVac ApSMar 1, 2022

As of March 1, 2022, Allan Rosetzsky has joined the board of directors of GlyProVac ApS.

Anders Boysen leaves the board of GlyProVac ApSMar 1, 2022

As of March 1, 2022, Anders Boysen has left the board of directors of GlyProVac ApS.

I/S Rødeledsvej registered as owner of GlyProVac ApSMar 1, 2022

As of March 1, 2022, I/S Rødeledsvej is registered as an owner of GlyProVac ApS with an ownership share of 5%.

GlycoPharma Holding ApS registered as owner of GlyProVac ApSMar 1, 2022

As of March 1, 2022, GlycoPharma Holding ApS is registered as an owner of GlyProVac ApS with an ownership share of 33%.

Tommi Petteri Kainu joins the board of GlyProVac ApSJan 1, 2022

As of January 1, 2022, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.

About GlyProVac ApS

GlyProVac ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Anders Boysen and Ann Zahle Andersen. The board consists of Ann Zahle Andersen (chair), Allan Rosetzsky, Kirsten Winther and Willem Adriaan de Jongh. The company's owners include Bente Kristiansen, Rossi Finans ApS and I/S Rødeledsvej. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -2,128,863 and a net result of DKK -5,168,999 compared with DKK -3,014,952 the year before. Equity in the 2025 report amounted to DKK -831,720.

Source: annual report 2025, Danish Business Authority

Other financial years